Abstract:Yun Zhong, 1– 3 Yufei Zhao, 4 Xin Meng, 2 Fan Wang, 2 Lei Zhou 1 1 Department of Dermatology, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China; 2 Department of Dermatology, Xiangya Hospital, Central South University, Changsha, People's Republic of China; 3 Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China; 4 Department of Gastrointestinal Surgery, Laboratory of Surgery, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China Correspondence: Lei Zhou, Department of Dermatology, the Third Affiliated Hospital, Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, Guangdong, 510630, People's Republic of China, Tel +020-85253333, Fax +020-85253336, Email Background: Rosacea, a recurring dermatological disorder, demands effective therapeutic approaches. Traditional Chinese medicine, particularly Liangxue Siwu Decoction (LXSWD), has shown promise in managing inflammatory skin diseases, such as rosacea. This study focuses on uncovering LXSWD's specific effects on the inflammatory symptoms of rosacea. Objective: Our research investigates LXSWD's therapeutic effectiveness in rosacea treatment and delves into its underlying mechanisms. Methods: Network pharmacology was utilized to identify LXSWD's key components and their targets in rosacea management, which were then validated by molecular docking. An in vivo rosacea-like model in LL-37-induced mice was developed, subdividing them into control, model, and LXSWD groups. The LXSWD group received oral administration (25.0 g/kg/day) for six days before model induction. Post-treatment evaluations included skin tissue analyses to verify our network pharmacology predictions. Results: Key active ingredients in LXSWD, such as quercetin, kaempferol, and luteolin, were identified alongside central target proteins like TNF and MMPs. Our molecular docking study confirmed the interactions between these ingredients and targets. Analyses through GO and KEGG pathways indicated LXSWD's role in mitigating inflammation, particularly influencing the TNF and IL-17 pathways. LXSWD treatment in vivo markedly alleviated LL-37-induced symptoms in mice, showing a marked reduction in inflammatory cytokines ( p < 0.05) and modulation of crucial genes ( p < 0.05). These results, supported by immunofluorescence analysis and Western blot, underline the modulatory effects of LXSWD on MMPs, offering significant protection against rosacea's inflammation alterations ( p < 0.05). Conclusion: Integrating network pharmacology, molecular docking, and in vivo experiments, this study elucidates LXSWD's potential mechanisms in rosacea treatment. It offers a novel theoretical framework for its clinical use in managing rosacea. Keywords: Liangxue siwu decoction, molecular docking, network pharmacology, rosacea, skin inflammation Rosacea is a chronic skin disorder that primarily affects the face, characterized by pronounced redness, papules, and pustules. This condition is often mistaken for other skin disorders such as acne, dermatitis, or allergic reactions, and it predominantly occurs in individuals with lighter skin tones. 1,2 Nonetheless, it can occur in people of all skin types. 3 The development of rosacea is believed to result from a combination of genetic and environmental factors. 4,5 Rosacea's onset is often linked to an overactive immune reaction, activated by a variety of stimuli. These include exposure to certain bacteria, mites, or specific infection that cause facial blood vessels to widen. 6,7 Additionally, several external factors, such as the consumption of hot beverages, spicy foods, alcohol, exposure to extreme temperatures, and emotional stress, can exacerbate rosacea symptoms by increasing blood flow to the skin or sustaining inflammation. While rosacea is not a life-endangering condition, it can lead to considerable emotional and psychological discomfort, causing affected individuals to feel self-conscious about their appearance. 8–10 For centuries, Traditional Chinese Medicine (TCM) has offered effective treatments for a variety of health issues, including skin conditions such as rosacea. 11–13 One of the notable treatments is the Liangxue Siwu Decoction (LXSWD), known for its potential therapeutic effects. According to ancient TCM principles, LXSWD is formulated to "cool the blood" and "nourish the yin", addressing the underlying imbalances believed to contribute to the development of rosacea. LXSWD's application is not limited to rosac -Abstract Truncated-

Supramolecular salicylic acid ameliorates rosacea-like eruptions by suppressing NLRP3-mediated inflammasome activation in mice

Dietary supplementation of n-3 PUFAs ameliorates LL37-induced rosacea-like skin inflammation via inhibition of TLR2/MyD88/NF-κB pathway

Clinical efficacy of 595 nm pulsed dye laser in combination with supramolecular salicylic acid in the treatment of rosacea

Anti-inflammatory Effects of Rosmarinic Acid in Lipopolysaccharide-Induced Mastitis in Mice

Activation of aryl hydrocarbon receptor ameliorates rosacea-like eruptions in mice and suppresses the TLR signaling pathway in LL-37-induced HaCaT cells

IL-17A-neutralizing antibody ameliorates inflammation and fibrosis in rosacea by antagonizing the CXCL5/CXCR2 axis

Cytotoxicity of Saikosaponin A targets HEKa cell through apoptosis induction by ROS accumulation and inflammation suppression via NF-κB pathway

Probiotics suppress LL37 generated rosacea-like skin inflammation by modulating the TLR2/MyD88/NF-κB signaling pathway

Isosilybin A exhibits anti-inflammatory properties in rosacea by inhibiting MAPK pathway and M1 macrophage polarization

Tranilast alleviates skin inflammation and fibrosis in rosacea-like mice induced by long-term exposure to LL-37

Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis

Effects of rosmarinic acid on the inflammatory response in allergic rhinitis rat models after PM2.5 exposure

Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway

Abietic acid ameliorates psoriasis-like inflammation and modulates gut microbiota in mice

Dendrobium polysaccharide (DOP) ameliorates the LL‐37‐induced rosacea by inhibiting NF‐κB activation in a mouse model

Salvianolic acid B remits LPS-induced injury by up-regulating miR-142-3p in MH7A cells

Unveiling the Mechanism of Liangxue Siwu Decoction in Treating Rosacea Through Network Pharmacology and in-vitro Experimental Validation

Syringic acid suppresses Cutibacterium acnes-induced inflammation in human keratinocytes via regulating the NLRP3/caspase-1/IL-1β signaling axis by activating PPARγ/Nrf2-antioxidant pathway

Sericic acid ameliorates DSS-induced ulcerative colitis in mice by modulating the NF-κB and Nrf2 pathways.

SERPINB3/B4 is Increased in Psoriasis and Rosacea Lesions and has Pro-inflammatory Effects in Mouse Models of these Diseases

Salubrinal protects against inflammatory response in macrophage and attenuates psoriasiform skin inflammation by antagonizing NF-κB signaling pathway